share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  07/22 13:22
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 15,202 shares of common stock on 07/22/2024, with an aggregate market value of approximately $7,555,394. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on various dates ranging from 02/13/2023 to 02/24/2024. The total number of shares acquired through these transactions was 14,702. This planned sale follows a recent history of transactions over the past three months, where a total of 16,767 shares were sold for gross proceeds of $7,510,499.
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 15,202 shares of common stock on 07/22/2024, with an aggregate market value of approximately $7,555,394. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on various dates ranging from 02/13/2023 to 02/24/2024. The total number of shares acquired through these transactions was 14,702. This planned sale follows a recent history of transactions over the past three months, where a total of 16,767 shares were sold for gross proceeds of $7,510,499.
Vertex Pharmaceuticals Inc. 的董事和高級職員Kewalramani Reshma計劃於2024年7月22日賣出15,202股普通股,市值約爲$7,555,394。這些普通股是作爲發行人通過不同日期(2023年2月13日至2024年2月24日)限制性股票注入報酬的一部分而獲得的。通過這些交易所獲得的股票總數爲14,702股。這次計劃出售的行動,是接下來三個月內多次交易的最新一筆,之前共賣出16,767股,總收益爲$7,510,499。
Vertex Pharmaceuticals Inc. 的董事和高級職員Kewalramani Reshma計劃於2024年7月22日賣出15,202股普通股,市值約爲$7,555,394。這些普通股是作爲發行人通過不同日期(2023年2月13日至2024年2月24日)限制性股票注入報酬的一部分而獲得的。通過這些交易所獲得的股票總數爲14,702股。這次計劃出售的行動,是接下來三個月內多次交易的最新一筆,之前共賣出16,767股,總收益爲$7,510,499。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息